QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
NYSE:OSH

Oak Street Health - OSH Price Target & Analyst Ratings

$27.38
-1.28 (-4.47%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$27.37
$29.13
50-Day Range
$18.71
$30.05
52-Week Range
$13.29
$30.89
Volume
2.03 million shs
Average Volume
3.70 million shs
Market Capitalization
$6.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.86

Oak Street Health Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 13 Analyst Ratings

Consensus Analyst Price Target

$30.86
12.70% Upside
High Prediction$43.00
Average Prediction$30.86
Low Prediction$18.00
TypeCurrent
2/2/22 to 2/2/23
1 Month Ago
1/3/22 to 1/3/23
3 Months Ago
11/4/21 to 11/4/22
1 Year Ago
2/2/21 to 2/2/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
9 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$30.86$30.87$31.60$53.92
Predicted Upside12.70% Upside30.88% Upside30.17% Upside27.68% Upside
Get Oak Street Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OSH and its competitors with MarketBeat's FREE daily newsletter.


OSH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OSH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oak Street Health Stock vs. The Competition

TypeOak Street HealthMedical CompaniesS&P 500
Consensus Rating Score
2.46
2.65
2.46
Consensus RatingHoldBuyHold
Predicted Upside12.70% Upside1,296.70% Upside7.34% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/12/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$35.00+18.64%
1/10/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$23.00 ➝ $33.00+46.21%
1/6/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$28.00 ➝ $21.00-1.22%
11/14/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight
11/9/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$32.00 ➝ $27.00+29.50%
9/12/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$32.00 ➝ $29.00+2.36%
8/9/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$37.00+26.24%
8/9/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$34.00+16.00%
8/8/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$31.00 ➝ $34.00+12.29%
7/27/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$25.00 ➝ $35.00+21.95%
7/26/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold
6/15/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$26.00 ➝ $18.00+14.29%
5/26/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$60.00 ➝ $26.00+42.47%
3/29/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
3/2/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$47.00 ➝ $43.00+98.80%
1/19/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$45.00 ➝ $34.00+68.82%
10/20/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$50.00+18.46%
9/7/2021Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$60.00+20.26%
4/20/2021Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Halper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$75.00+28.10%
1/28/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$62.00+19.92%
1/6/2021BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
8/31/2020JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$52.00+14.51%
8/31/2020William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Daniels
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
(Data available from 2/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












OSH Price Target - Frequently Asked Questions

What is Oak Street Health's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Oak Street Health stock is Hold based on the current 1 sell rating, 5 hold ratings and 7 buy ratings for OSH. The average twelve-month price prediction for Oak Street Health is $30.86 with a high price target of $43.00 and a low price target of $18.00. Learn more on OSH's analyst rating history.

Do Wall Street analysts like Oak Street Health more than its competitors?

Analysts like Oak Street Health less than other Medical companies. The consensus rating for Oak Street Health is Hold while the average consensus rating for medical companies is Buy. Learn more on how OSH compares to other companies.

Is Oak Street Health being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Oak Street Health's stock had 2 upgrades and 1 downgrade by analysts.

Does Oak Street Health's stock price have much upside?

According to analysts, Oak Street Health's stock has a predicted upside of 29.83% based on their 12-month price targets.

What analysts cover Oak Street Health?

Oak Street Health has been rated by Canaccord Genuity Group, Morgan Stanley, Raymond James, SVB Leerink, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:OSH) was last updated on 2/2/2023 by MarketBeat.com Staff